We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
RPGLIFE.NSE

Price
2316.40
Stock movement up
+10.70 (0.46%)
Company name
RPG Life Sciences Limited
Exchange
(NSE
,
Currency
INR
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
38.31B
Ent value
38.51B
Price/Sales
5.75
Price/Book
6.92
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
17.78
Forward P/E
-
PEG
-
EPS growth
44.58%
1 year return
1.63%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-12-12

DIVIDENDS

RPGLIFE.NSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E17.78
Price to OCF42.98
Price to FCF181.31
Price to EBITDA20.82
EV to EBITDA20.92

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales5.75
Price to Book6.92
EV to Sales5.78

FINANCIALS

Per share

Per share data
Current share count16.54M
EPS (TTM)-
FCF per share (TTM)-

Income statement

Income statement data
Revenue (TTM)-
Gross profit (TTM)-
Operating income (TTM)-
Net income (TTM)-
EPS (TTM)-
EPS (1y forward)-

Margins

Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash1.32B
Net receivables1.19B
Total current assets4.88B
Goodwill0.00
Intangible assets199.60M
Property, plant and equipment0.00
Total assets7.06B
Accounts payable979.20M
Short/Current long term debt0.00
Total current liabilities1.44B
Total liabilities1.52B
Shareholder's equity5.54B
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-
Capital expenditures (TTM)-
Free cash flow (TTM)-
Dividends paid (TTM)-

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-
Return on Invested Capital-
Cash Return on Invested Capital-

STOCK INFORMATION

Stock chart

Stock price data
Open2290.00
Daily high2330.00
Daily low2287.80
Daily Volume6K
All-time high2828.55
1y analyst estimate478.00
Beta-0.33
EPS (TTM)-
Dividend per share0.00
Ex-div date27 Jun 2025
Next earnings date22 Jan 2026

Downside potential

Downside potential data
RPGLIFE.NSES&P500
Current price drop from All-time high-18.11%-1.08%
Highest price drop-30.37%-19.00%
Date of highest drop9 Apr 20258 Apr 2025
Avg drop from high-18.61%-2.64%
Avg time to new high99 days6 days
Max time to new high294 days89 days
COMPANY DETAILS
RPGLIFE.NSE (RPG Life Sciences Limited) company logo
Marketcap
38.31B
Marketcap category
Large-cap
Description
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and finished dosage formulations for various therapies, which include nephrology, rheumatology, oncology, gastroenterology, cardiology, orthopedics, nutritional, diabetology, respiratory, neuropsychiatry, urology, vitamins and minerals, gastrointestinal, pain management, anti-diabetic, gynecology and pediatrics, cardiovascular, pediatrics, neurology, anti-dengue, dermatology, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.
Employees
1331
Website
https://www.rpglifesciences.com
Investor relations
-
SEC filings
RPGLIFE.NSE SEC filings
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesFeatured ArticlesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved